NCT00569413

Brief Summary

The current study combines a molecular genetic perspective, self report and brain imaging to the study of human sexuality in control subjects and individuals from a sexual disorder clinic. The investigators hypothesize that the variability in components of the brain dopaminergic system expressed in the mesolimbic reward system can explain variability in human sexuality, especially in desire and pleasure associated with sex.

Trial Health

20
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2011

Shorter than P25 for all trials

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 6, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 7, 2007

Completed
3.3 years until next milestone

Study Start

First participant enrolled

April 1, 2011

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2011

Completed
Last Updated

June 10, 2010

Status Verified

June 1, 2010

Enrollment Period

6 months

First QC Date

December 6, 2007

Last Update Submit

June 9, 2010

Conditions

Keywords

Sexbrain imagingdopaminesexual disorder

Outcome Measures

Primary Outcomes (1)

  • Brain Imaging data of DRD2 receptor occupancy during watching a sex videotape and neutral videotape

    2 Brain imaging sessions a week apart

Secondary Outcomes (1)

  • Questionnaire ratings of human sexuality, pleasure, and anticipatory reward

    Taken during brain scans

Study Arms (2)

1

Healthy control subjects (n=20) age 21-65 who do not suffer from a psychiatric diagnosis or neurological damage, are under age, or are pregnant women

2

20 patients who suffer from sexual disorder (reduced sexual desire or sexual function) from a sexual disorder clinic, age 21-65, without any other psychiatric disorder, neurological damage, are not under age or pregnant women.

Eligibility Criteria

Age21 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A group of healthy volunteers from the general public. A group of patients who suffer from sexual disorder from a primary care clinic.

You may qualify if:

  • Healthy volunteers and patients
  • Age 21-65
  • Male or female

You may not qualify if:

  • Psychiatric diagnosis/psychosis
  • Neurological damage associated with loss of consciousness
  • Infectious disease HIV
  • Herpes
  • Syphilis
  • Hyperactivity treated with ritalin
  • Pregnant women
  • Under age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Sexual Dysfunctions, PsychologicalErectile DysfunctionCoitusSexual Dysfunction, Physiological

Condition Hierarchy (Ancestors)

Mental DisordersGenital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital DiseasesSexual BehaviorBehavior

Study Officials

  • Aviv M Weinstein, Ph.D

    Hadasah Medical Organization, Jerusalem Israel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 6, 2007

First Posted

December 7, 2007

Study Start

April 1, 2011

Primary Completion

October 1, 2011

Study Completion

October 1, 2011

Last Updated

June 10, 2010

Record last verified: 2010-06